Borosil Scientific Ltd Valuation Shifts Signal Renewed Price Attractiveness

36 minutes ago
share
Share Via
Borosil Scientific Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change comes amid a challenging market backdrop and evolving sector dynamics, prompting a reassessment of the stock’s price attractiveness relative to its historical averages and peer group.
Borosil Scientific Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Reflect Improved Price Appeal

As of 1 Oct 2026, Borosil Scientific’s P/E ratio stands at 22.76, a figure that positions the stock favourably against its recent valuation history and peer comparisons. The P/E multiple, a key indicator of how much investors are willing to pay for each rupee of earnings, has contributed significantly to the stock’s upgraded valuation grade from fair to attractive. Complementing this, the price-to-book value ratio of 2.29 suggests that the market is valuing the company at just over twice its net asset value, a level that remains reasonable within the industrial products sector.

Other valuation multiples such as EV to EBIT (19.01) and EV to EBITDA (13.45) further support the narrative of improved price attractiveness. These enterprise value-based ratios indicate that the company’s earnings before interest, taxes, depreciation, and amortisation are being valued at a discount relative to some peers, signalling potential upside for investors seeking value in the micro-cap industrial products space.

Comparative Analysis with Industry Peers

When benchmarked against key competitors, Borosil Scientific’s valuation stands out as notably more attractive. For instance, Saint-Gobain Sekurit, a major peer, is classified as very expensive with a P/E of 22.96 and an EV/EBITDA of 16.5, both higher than Borosil’s respective multiples. Similarly, Agarwal Toughened Glass is also deemed very expensive despite a lower P/E of 14.83, reflecting market concerns about growth or profitability sustainability.

On the other hand, Empire Industries is rated very attractive with a P/E of 11.34 and EV/EBITDA of 7.6, indicating a more compelling valuation but also potentially reflecting differences in scale, growth prospects, or risk profile. Borosil’s PEG ratio of 0.27, which adjusts the P/E for earnings growth, is among the lowest in the peer group, underscoring the stock’s undervaluation relative to its growth potential.

Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!

  • - Long-term growth stock
  • - Multi-quarter performance
  • - Sustainable gains ahead

Invest for the Long Haul →

Financial Performance and Quality Metrics

Borosil Scientific’s return on capital employed (ROCE) of 13.69% and return on equity (ROE) of 9.64% reflect a moderate but stable profitability profile. While these returns are not industry-leading, they are consistent with the company’s micro-cap status and industrial products sector norms. The absence of a dividend yield indicates that the company is likely reinvesting earnings to support growth initiatives rather than returning cash to shareholders at this stage.

From a market perspective, the stock has underperformed the Sensex over recent periods, with a one-month return of -8.47% compared to the Sensex’s -6.19%, and a year-to-date return of -5.08% versus the Sensex’s -14.95%. This relative resilience amid broader market weakness may be a factor in the improved valuation sentiment.

Market Capitalisation and Trading Range

Classified as a micro-cap stock, Borosil Scientific’s current market price of ₹113.95 is closer to its 52-week low of ₹96.65 than its high of ₹181.25, indicating a significant price correction over the past year. The stock’s day range on 1 Oct 2026 was ₹113.80 to ₹116.40, with a slight day decline of 0.44%, reflecting subdued trading activity and cautious investor sentiment.

The downgrade in the Mojo Grade from Hold to Sell on 3 Sep 2026, with a current Mojo Score of 42.0, signals a cautious stance from the rating agency, likely influenced by the company’s micro-cap status and sector risks. However, the shift in valuation grade to attractive suggests that the price may now offer a more compelling entry point for value-oriented investors willing to accept the associated risks.

Sector and Industry Context

The industrial products sector has faced headwinds in recent quarters due to global supply chain disruptions and fluctuating demand patterns. Borosil Scientific’s valuation improvement amidst these challenges may indicate market recognition of its operational resilience or potential for recovery. Compared to riskier peers such as Jai Mata Glass and Triveni Glass, which are loss-making and carry risky valuations, Borosil’s stable earnings and reasonable multiples stand out.

Borosil Scientific Ltd or something better? Our SwitchER feature analyzes this micro-cap Industrial Products stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Investment Implications and Outlook

The recent valuation upgrade for Borosil Scientific Ltd suggests that the stock is now priced more attractively relative to its earnings and book value, especially when compared to its peer group. Investors seeking exposure to the industrial products sector may find the stock’s current multiples appealing, particularly given its PEG ratio of 0.27, which implies undervaluation relative to growth prospects.

However, the micro-cap classification and the recent downgrade in Mojo Grade to Sell highlight the inherent risks, including liquidity constraints and sector volatility. Prospective investors should weigh these factors carefully and consider the stock’s relative underperformance against the broader market before committing capital.

In summary, Borosil Scientific’s valuation parameters have shifted favourably, signalling a potential opportunity for value investors. Yet, caution remains warranted given the company’s size, sector challenges, and recent rating changes.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News